FDA clears new blood-based biomarker test that targets tau

Reports

3

Domains carrying it

3

First reported

25 August 2026

Latest report

3 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 25 August 2026FDA clears new blood-based biomarker test that targets tauradiologybusiness.com
2. 3 September 2026FDA approves new Alzheimer's blood test that family doctors can orderabc-7.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA clears Roche, Lilly Alzheimer's blood tests; Regenxbio gene therapy trial halted by FDA again4 reports · 4 domains · 28 August 2026
• FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics4 reports · 4 domains · 15 August 2026
• GRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs6 reports · 6 domains · 12 August 2026
• FDA approves Lytenava for wet AMD2 reports · 2 domains · 2 August 2026
• Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...5 reports · 5 domains · 27 August 2026

◆ Share

◆ Evidence

3 reports · 3 domains

• FDA approves new Alzheimer's blood test that family doctors can orderabc-7.com · 3 September 2026
• Fda clears Roche and Eli Lilly blood test expanding Alzheimer diagnosisbiz.chosun.com · 25 August 2026
• FDA clears new blood-based biomarker test that targets tauradiologybusiness.com · 25 August 2026